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Abstract
Background: Various studies demonstrate better patient outcome and higher thrombolysis rates achieved by centralized
stroke care compared to decentralized care, i.e. community hospitals. It remains largely unclear how to improve
thrombolysis rate in decentralized care. The aim of this simulation study was to assess the impact of previously identified
success factors in a central model on thrombolysis rates and patient outcome when implemented for a decentral model.
Methods: Based on a prospectively collected dataset of 1084 ischemic stroke patients, simulation was used to replicate
current practice and estimate the effect of re-organizing decentralized stroke care to resemble a centralized model. Factors
simulated included symptom onset call to help, emergency medical services transportation, and in-hospital diagnostic
workup delays. Primary outcome was proportion of patients treated with thrombolysis; secondary endpoints were good
functional outcome at 90 days, Onset-Treatment-Time (OTT), and OTT intervals, respectively.
Results: Combining all factors might increase thrombolysis rate by 7.9%, of which 6.6% ascribed to pre-hospital and 1.3% to
in-hospital factors. Good functional outcome increased by 11.4%, 8.7% ascribed to pre-hospital and 2.7% to in-hospital
factors. The OTT decreased 17 minutes, 7 minutes ascribed to pre-hospital and 10 minutes to in-hospital factors. An
increase was observed in the proportion thrombolyzed within 1.5 hours; increasing by 14.1%, of which 5.6% ascribed to
pre-hospital and 8.5% to in-hospital factors.
Conclusions: Simulation technique may target opportunities for improving thrombolysis rates in acute stroke. Pre-hospital
factors proved to be the most promising for improving thrombolysis rates in an implementation study.
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Introduction
Treatment with tissue plasminogen activator (tPA) or throm-
bolysis is the most effective therapy for acute ischemic stroke
patients within the first 4.5 hours following the onset of stroke
symptoms [1,2]. However, thrombolysis is substantially underused.
Of all stroke patients, currently between 1–8% [3–5] are treated
with tPA worldwide and around 11% (ranging from 4–26%)
within the Netherlands [6], while 24–31% may be achieved in
optimized settings [7,8]. Reasons for this undertreatment are
multi-factorial. Patients may not be familiar with the symptoms of
a stroke or may not know how to act. Also, access to stroke care
and expertise may vary by location [9,10]. Other factors
influencing the use of thrombolysis ensue from the organization
of acute stroke care. Recently we demonstrated a 50% greater
likelihood and up to 22% overall rate of treatment with
thrombolysis achieved by a stroke center in a centralized
organizational model versus nine community hospitals united in
a decentralized organizational system of acute stroke care [11].
So far, it remains largely unclear how to improve thrombolysis
delivery in decentralized stroke care; i.e. community hospitals. A
method to study improvement of thrombolysis delivery is using
Randomized Controlled Trials (RCTs). Although the benefits of
RCTs have been clearly established in case of single interventions,
their efficacy may be limited in case of complex patient pathways
such as thrombolysis. For example, two recently published RCTs
showed nonsignificant increases in thrombolysis rate following an
intensive multicomponent intervention [12,13]. Taken together,
these studies focused on singular aspects of thrombolysis delivery
(i.e. the in-hospital phase) and seem to yield very little gains- in
terms of an increase in thrombolysis use- for the time and money
invested. This warrants the question whether alternative research
strategies are needed to study delivery of thrombolysis.
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Various studies have shown how simulation models may be used
as an efficient alternative or precursor to clinical trials, for example
by predicting the prognosis after aortic heart valve replacement
before implementation of the therapy [14], and studying the
clinical benefit of reducing in-hospital delays to maximize the
population benefit of thrombolysis in acute ischemic stroke [15].
As opposed to RCTs, simulation models allow for studying the
effect of multiple factors along the entire stroke pathway at high
pace and low costs.
The aim of this simulation study was to assess the impact of
previously identified success factors in a central model on
thrombolysis rates and patient outcome when implemented for a
decentral model.
Methods
Study setting and patients
In the North of The Netherlands a centralized and a
decentralized organizational model co-exist. The centralized
model covers the catchment area of 4 hospitals, in which
thrombolysis is only provided by University Medical Center
Groningen (UMCG) acting as a designated stroke center. The
decentralized model is adopted by 9 community hospitals all
providing thrombolysis for their own catchment area. From
February 1 to July 31 2010 all ischemic stroke patients admitted
or referred to hospitals were registered. For both models identical
protocols for tPA treatment (adjusted ECASS III [16]), identi-
fication and triage of suspected stroke patients, and 911 systems
were used. Further details on population densities and access to
healthcare services are provided in a previously published paper
[11].
Simulation model
A simulation model was developed using Plant Simulation
software [17]. Factors in which the central model performed
significantly better than the decentral model were incorporated in
the simulation model: lapse between symptom onset to call for
help, first responder; i.e. 911 or General Practitioner (GP),
Emergency Medical Services (EMS) transport, high priority
transport by EMS, and the time from hospital arrival to
neurological- and neuroimaging (Computed Tomography, CT)
examination. Data collected in a previously performed prospective
study of 801 diagnosed ischemic stroke patients admitted in a
decentralized model and 283 in a centralized model were used as
input for the simulation model [11]. We aimed to simulate current
practice and compare it with scenarios in which we implemented
success factors of the central model in the decentral model. Next,
the impact on thrombolysis rates and patient outcome were
assessed for single factors and combinations thereof. Probability
distributions derived from empirical data were used to model
event rates, activity durations and diagnostic accuracy. Details on
stroke pathway setup, simulation methodology, and model data
are provided in Text S1. In the model, 10,000 patients progressed
along the stroke pathway.
Data collection
Data of ischemic stroke patients were collected for both the
pre-hospital and in-hospital phase by ambulance personnel and
experienced stroke neurologists. All data were entered directly
into a web-based database to ensure high quality of data. Patients
not transported by EMS were referred by the GP and arrived at
the hospital by self transport in case no longer eligible for
thrombolysis and the medical condition allowed such (i.e. stable
or not).
Outcome measures
The primary end-point was the proportion of patients treated
with thrombolysis. Secondary end-points were proportion of
patients with good functional outcome at 90 days (modified
Rankin Scale 0–1), Onset-Treatment-Time (OTT), and shift of
OTT to a shorter time window, because the benefit of
thrombolysis is strongly time dependent, the sooner the better.
Statistical analysis
Mann-Whitney U tests and Chi-square tests were performed for
continuous and categorical variables. A p-value ,0.05 was
considered statistically significant. SPSS 20.0 for windows software
package (Chicago, Il) was used.
Informed consent
Informed consent was obtained from all subjects participating in
the previous observational study and extended for current use
[11]. Written consent was given by the patients for their
information to be stored in the hospital database and used for
research. The study was approved by the institutional review
board of the University Medical Center Groningen.
Results
Observational study – performance for organizational
models
In the observational study, the difference in thrombolysis rate
between the decentralized and centralized model was 7.8%
(14.1% vs. 21.9%, respectively). Table 1 describes the performance
for each factor investigated in both models, and Table 2 shows the
results of the nine scenarios selected for this study on primary and
secondary outcome measures. Details on the distributions under-
lying activity durations and diagnostic accuracy of both the
decentralized- and centralized organizational model are presented
in Table S1 and Table S2, respectively. Key activities of the acute
stroke pathway and treatment decision are presented in Figure S1
and Figure S2, respectively.
Primary outcome
Compared to current practice, improving all factors to the level
of the central model might increase thrombolysis rate by 7.9%, of
which 6.6% ascribed to pre-hospital factors, and 1.3% to in-
hospital factors. Of all pre-hospital factors, improving lapse
between symptom onset to call for help contributed 1.7% to the
total effect, 911 calls 0.9%, EMS transport 2.8%, and high priority
EMS transport 0.2%. The remaining 1.0% is caused by an
interaction effect between symptom onset to call for help and EMS
transport. Of all in-hospital factors, 0.5% can be attributed to
neurological examination, and 0.8% to neuroimaging examina-
tion.
Secondary outcomes
Improving all factors led to an 11.4% increase in patients with
good functional outcome, of which 8.7% ascribed to pre-hospital
factors and 2.7% to in-hospital factors. The OTT decreased
17 minutes; of which 7 minutes ascribed to pre-hospital factors
and 10 minutes to the in-hospital factors. A shift was observed in
the proportion of patients thrombolyzed within 1.5 hours;
increasing by 14.1%, of which 5.6% ascribed to pre-hospital
factors, and 8.5% to in-hospital factors. Treatment between 1.5–
3.0 and 3.0–4.5 hours decreased by 9.3% and 4.8%, respectively;
of which 4.3% and 2.2% attributed to pre-hospital factors and
5.0% and 2.6% to in-hospital factors, respectively. Figures 1 and 2
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show the proportion of patients treated with thrombolysis
according the OTT intervals and the proportion of patients with
good functional outcome, respectively.
Discussion
This simulation study quantifies the potential benefit of
implementing success factors from a centralized organizational
Table 1. Organizational model performance for the pre- and in-hospital acute stroke pathway.
Centralized model Decentralized model
N 283 801
Pre-hospital phase
Symptom onset to call for help time, valid cases 152 (53.7) 249 (31.1)*
Median (min) 40.5 36.5
First responder
General practitioner (%) 135 (47.7) 456 (56.9){
911 (%) 84 (29.7) 184 (23.0){
Transported by EMS (%) 213 (75.3) 462 (57.8)*
High priority transportation by EMS (%) 170 (79.8) 310 (67.1)*
In-hospital phase
In-hospital diagnostic workup, median (min)
Time to neurological examination 0.0 4.0*
Time to neuroimaging examination 8.0 22.0*




Table 2. Re-configuration decentralized model: results simulation experiments.
tPA rate (95% CI)
OTT min
(95% CI) tPA 0–1.5 hr (95% CI) tPA 1.5–3.0 hr (95% CI)
tPA 3.0–4.5 hr
(95% CI) mRS 0–1`
Scenario
0. Current practice 14.4% (13.7% –15.1%) 134 (63–235) 14.3% (12.6% –16.3%) 70.5% (68.1% –72.8%) 15.2% (13.4% –17.1%) 14.7%
Pre-hospital phase
1. Symptom onset
to call for help
16.1% (15.4% –16.8%) 128 (50–238) 21.0% (19.0% –23.0%) 64.7% (62.3% –67.0%) 14.4% (12.7% –16.2%) 17.5%
2. First responder 15.3% (14.6% –16.0%) 130 (63–235) 15.5% (13.8% –17.4%) 71.8% (69.5% –74.0%) 12.7% (11.1% –14.5%) 15.9%
3. EMS transport 17.2% (16.4% –17.9%) 134 (67–235) 13.2% (11.7% –14.9%) 73.0% (70.9% –75.1%) 13.8% (12.2% –15.5%) 17.5%
4. High priority
transport by EMS
14.6% (13.9% –15.3%) 133 (64–240) 14.8% (13.1% –16.7%) 70.1% (67.7% –72.4%) 15.1% (13.4% –17.1%) 15.0%
5. Combining all
pre-hospital scenarios




14.9% (14.2% –15.6%) 130 (63–235) 17.1% (15.3% –19.1%) 69.9% (67.6% –72.2%) 13.0% (11.4% –14.8%) 15.7%
7. Neuroimaging
examination
15.2% (14.5% –15.9%) 127 (56–232) 20.0% (18.1% –22.1%) 66.9% (64.5% –69.2%) 13.1% (11.5% –14.9%) 16.4%
8. Combing both
in-hospital scenarios
15.4% (14.8% –16.2%) 124 (55–230) 22.8% (20.8% –25.0%) 65.5% (63.1% –67.9%) 11.7% (10.2% –13.4%) 17.2%
9. Combining all
scenarios
22.3% (21.5% –23.1%) 117 (32–236) 28.4% (26.8% –30.3%) 61.2% (59.2% –63.2%) 10.4% (9.3% –11.8%) 26.1%
tPA indicates tissue plasminogen activator; CI, confidence interval; OTT, onset-treatment-time; mRS, modified rankin scale; EMS, emergency medical services.
`Indicates the proportion of patients with good outcome (mRS 0–1) ascribed to treatment with thrombolysis. The number needed to treat to achieve one patient
with mRS 0–1 at 90 days for OTT 0–90=4.5, OTT 91–180=9.0, OTT 181–270=14.1 [21].
doi:10.1371/journal.pone.0079049.t002
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model in a decentralized model. Combining all factors raised
thrombolysis rates by 7.9% thereby closing the gap observed
between both models. Furthermore, our model demonstrates that
the proportion of patients with a good functional outcome (mRS
0–1) may increase by 11.4% and those thrombolyzed within
1.5 hours by 14.1%.
This simulation study provides an example of an alternative
research method to study delivery of thrombolysis in acute
ischemic stroke. Contrary to traditional approaches that evaluate
improvement strategies (i.e. RCTs), simulation models may be
better suited to investigate multiple factors of stroke system
organization simultaneously and allow for quicker answers at
lower costs [15]. Instead of time-consuming and expensive trials
such as double-blinded randomized trials, we advocate action
research. This means implementing critical success factors
determined from the simulation study in the existing acute stroke
pathway and study the effects of interventions with baseline
measurements. Simulation experiments obviously precede imple-
mentation to check whether comparable results can actually be
achieved in clinical practice. By using the results obtained from
Figure 1. Number of patients treated with thrombolysis according to onset-treatment-time (OTT) intervals.
doi:10.1371/journal.pone.0079049.g001
Figure 2. Patient outcome at 90 days for onset-treatment-time (OTT) intervals.
doi:10.1371/journal.pone.0079049.g002
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simulation, implementation studies may be tailored towards
improving factors impacting most on thrombolysis rates and
patient outcome, while excluding others that do not.
Based on the identified potential for improving thrombolysis
rates and patient outcomes pre-hospital factors seem primary
targets for change. The importance of the pre-hospital phase in
advancing the acute stroke care pathway is supported by a recent
review article emphasizing that every link in the care pathway
matters and should be studied for potential improvements [18]. In
addition, we observed an interaction effect between improving
symptom onset to call for help and EMS transport. This
interaction effect may be explained by a volume effect – meaning
more patients arriving at the hospital in time for thrombolysis, and
by shortening the time to treatment for those already thrombo-
lyzed. As treatment rates with thrombolysis are relatively high in
our study compared to international standards, we would expect
even larger effects when implemented in regions with low
treatment rates.
Our study has limitations. Firstly, we were limited by the
documentation of symptom onset times by ambulance and
hospital personnel, i.e. possibly some of the ‘unknown’ onset
times were actually known but never documented. However, the
proportion of patients with unknown or estimated onset times was
comparable to or even better than in previous studies [19,20].
Secondly, the interaction between hospital size, i.e. stroke center
and community hospitals, may be difficult to interpret because
requirements of stroke centers are such that community hospitals
are unlikely to meet them.
Conclusions
This study demonstrates that simulation may be employed as
research tool to target opportunities for improving the acute stroke
care pathway and therefore thrombolysis rates. Pre-hospital factors
proved to be the most promising targets for improving acute stroke
care in an implementation study.
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